Abstract:Infantile hemangioma (IH) is a common and benign vascular neoplasms, which has a high incidence in children. Although IH is benign, some patients experience complications such as pain, functional impairment, and permanent disfigurement. Treatment options for IH include corticosteroids, surgery, vincristine, interferon or cyclophosphamide. However, none of these modalities are ideal due to restrictions or potential serious side effects. There is thus a great need to explore novel treatments for IH with less side effects. Angiogenesis, vasculogenesis and tumorigenesis are the main features of IH. Tanshen is mostly used in Chinese traditional medicine to treat hematological abnormalities. Therefore, the aim of our study was to evaluate anti-proliferation and anti-angiogenesis effects on hemangiomas cells by extracted Tanshen compounds compared with propranolol, the first-line treatment for IH currently, both in vitro and in vivo. Cell viability, apoptosis, protein expression and anti-angiogenesis were analyzed by CCK8, Annexin V staining, Western blot and tube formation, respectively. The anti-tumor activity in vivo was evaluated using a mouse xenograft model. Fourteen major compounds extracting from Tanshen were screened for their ability to inhibit hemangiomas cells. Of the 14 compounds investigated, 15,16-Dihydrotanshinone I (DHTS) was the most potent modulator of EOMA cell biology. DHTS could significantly decrease EOMA cells proliferation by inducing cell apoptosis, which is much more efficient than propranolol in vitro. DHTS increased the expression of several apoptosis-related proteins, including caspase9, caspase3, PARP, AIF, BAX, cytochrome c, caspase8 and FADD and significantly inhibited angiogenesis, as indicated by reduced tube formation and diminished expression of vascular endothelial cell growth factor receptor 2 and matrix metalloproteinase 9. In nude mice xenograft experiment, DHTS (10 mg/kg) could significantly inhibit the tumor growth of EOMA cells as well as propranolol (40 mg/kg). Our study showed that DHTS was much more effective than propranolol in inhibiting hemangiomas proliferation and angiogenesis in vitro and in vivo, which could have potential therapeutic applications for treatment of IH.

Proteomic analysis of mitochondria from infantile hemangioma endothelial cells treated with sodium morrhuate and its liposomal formulation.

Delivery of Sodium Morrhuate to Hemangioma Endothelial Cells Using Immunoliposomes Conjugated with Anti-Vegfr2/kdr Antibody

The Effect of Lipo-Sodium Morrhuate on Human Hemangioma Endothelial Cells

[Study of Immunolipo-Sodium Morrhuate Applied on Human Hemangioma Endothelial Cells in Vitro].

Enhanced Efficacy of Propranolol Therapy for Infantile Hemangiomas Based on a Mesoporous Silica Nanoplatform Through Mediating Autophagy Dysfunction

Induction of apoptosis in infantile hemangioma endothelial cells by propranolol.

Propranolol‐Loaded Mesoporous Silica Nanoparticles for Treatment of Infantile Hemangiomas

Engineered exosomes for targeted delivery of miR-187-3p suppress the viability of hemangioma stem cells by targeting Notch signaling

Exosome-derived Mir-196B-5p Facilitates Intercellular Interaction in Infantile Hemangioma Via Down-Regulating CDKN1B

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation

Revealing the mechanism of 755-nm long-pulsed alexandrite laser in inhibiting infantile hemangioma endothelial cells through transcriptome sequencing

Surviving Inhibition Induces Cell Cycle Arrest and Disrupts Multipotency in Haemangioma Stem Cells.

The research for P53.MDM2 in propranolol-induced apoptosis in hemangioma endothelial cell

15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor I

Combinative effects of β -elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma

Apelin Receptor Can Act As a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma

15, 16-Dihydrotanshinone I Inhibits Hemangiomas Through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo.

Effects of Propranolol and Timolol on Proliferation and Apoptosis of Hemangioma Stem Cells

The effect of miR-29a up-regulation on the biological activity of infantile hemangioma endothelial cells

Microneedle delivery system with rapid dissolution and sustained release of bleomycin for the treatment of hemangiomas

Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.